Oliver Sartor

1.5k total citations · 1 hit paper
38 papers, 944 citations indexed

About

Oliver Sartor is a scholar working on Pulmonary and Respiratory Medicine, Renewable Energy, Sustainability and the Environment and Environmental Engineering. According to data from OpenAlex, Oliver Sartor has authored 38 papers receiving a total of 944 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 13 papers in Renewable Energy, Sustainability and the Environment and 9 papers in Environmental Engineering. Recurrent topics in Oliver Sartor's work include Prostate Cancer Treatment and Research (12 papers), Environmental Impact and Sustainability (9 papers) and Climate Change Policy and Economics (9 papers). Oliver Sartor is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Environmental Impact and Sustainability (9 papers) and Climate Change Policy and Economics (9 papers). Oliver Sartor collaborates with scholars based in United States, France and Germany. Oliver Sartor's co-authors include Karsten Neuhoff, Manfred Fischedick, Max Åhman, Chris Bataille, Lars J Nilsson, Stefan Lechtenböhmer, S. Stiebert, Henri Waisman, Amandine Denis-Ryan and Tom Spencer and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Oliver Sartor

34 papers receiving 896 citations

Hit Papers

A review of technology and policy deep decarbonization pa... 2018 2026 2020 2023 2018 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oliver Sartor United States 14 321 256 255 153 129 38 944
Sascha Samadi Germany 12 212 0.7× 246 1.0× 196 0.8× 120 0.8× 210 1.6× 39 742
Henri Waisman France 15 547 1.7× 435 1.7× 419 1.6× 176 1.2× 166 1.3× 23 1.2k
Vincent de Gooyert Netherlands 12 137 0.4× 186 0.7× 211 0.8× 156 1.0× 111 0.9× 32 959
James Glynn Ireland 16 305 1.0× 308 1.2× 330 1.3× 369 2.4× 322 2.5× 33 1.2k
Stefan Lechtenböhmer Germany 14 331 1.0× 408 1.6× 477 1.9× 290 1.9× 233 1.8× 88 1.4k
Huiming Zhang China 20 525 1.6× 191 0.7× 228 0.9× 87 0.6× 261 2.0× 50 1.4k
Peter Erickson United States 16 533 1.7× 468 1.8× 295 1.2× 64 0.4× 122 0.9× 61 1.2k
Ken Oshiro Japan 19 442 1.4× 389 1.5× 387 1.5× 144 0.9× 370 2.9× 51 1.1k
Samuel Carrara Italy 16 341 1.1× 391 1.5× 278 1.1× 112 0.7× 395 3.1× 35 1.0k
Hanna Brauers Germany 9 227 0.7× 238 0.9× 88 0.3× 63 0.4× 115 0.9× 17 739

Countries citing papers authored by Oliver Sartor

Since Specialization
Citations

This map shows the geographic impact of Oliver Sartor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Sartor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Sartor more than expected).

Fields of papers citing papers by Oliver Sartor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Sartor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Sartor. The network helps show where Oliver Sartor may publish in the future.

Co-authorship network of co-authors of Oliver Sartor

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Sartor. A scholar is included among the top collaborators of Oliver Sartor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Sartor. Oliver Sartor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zarka, Jonathan, Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, et al.. (2025). 2403P LuRa: Efficacy and Tolerability of Radium-223 Following [177Lu]Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer. Annals of Oncology. 36. S1223–S1223.
2.
Lukka, Himu, Stephanie L. Pugh, William U. Shipley, et al.. (2025). Long-Term Results of NRG/RTOG 9601, a Randomized Trial of Radiation With or Without Antiandrogens in Patients Receiving Salvage Prostate Bed Radiation Therapy Postprostatectomy. International Journal of Radiation Oncology*Biology*Physics. 123(4). 990–999. 1 indexed citations
3.
Ravi, Praful, Wanling Xie, Marc Buyse, et al.. (2024). Refining Risk Stratification of High-risk and Locoregional Prostate Cancer: A Pooled Analysis of Randomized Trials. European Urology. 87(2). 217–224. 2 indexed citations
4.
Dorff, Tanya B., et al.. (2024). Navigating therapeutic sequencing in the metastatic castration-resistant prostate cancer patient journey. Prostate Cancer and Prostatic Diseases. 28(3). 672–683. 5 indexed citations
5.
Murthy, Vishnu, Andrew F. Voter, Kathleen Nguyen, et al.. (2024). Efficacy and Toxicity of [177Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data. Journal of Nuclear Medicine. 65(11). 1740–1744. 4 indexed citations
6.
Morris, Michael J., Jeffrey Y.C. Wong, Luke T. Nordquist, et al.. (2024). A phase 1 study of JNJ-69086420 (JNJ-6420), an actinium-225 (225Ac) -labeled antibody targeting human kallikrein 2 (hK2), for metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 42(16_suppl). 5010–5010. 7 indexed citations
7.
Sartor, Oliver, Thomas A. Hope, Jérémie Calais, & Wolfgang P. Fendler. (2021). Oliver Sartor Talks with Thomas A. Hope, Jeremie Calais, and Wolfgang P. Fendler About FDA Approval of PSMA. Journal of Nuclear Medicine. 62(2). 146–148. 13 indexed citations
8.
Sartor, Oliver, et al.. (2018). Accelerating Sustainable Mobility with Autonomous Vehicles. SHILAP Revista de lepidopterología. 3 indexed citations
9.
Spencer, Tom, Oliver Sartor, Sascha Samadi, et al.. (2017). Tracking sectoral progress in the deep decarbonisation of energy systems in Europe. Energy Policy. 110. 509–517. 31 indexed citations
10.
Caldecott, Ben, Oliver Sartor, & Tom Spencer. (2017). Lessons from previous ‘coal transitions’ high-level summary for decision-makers. 21 indexed citations
11.
Munnings, Clayton, et al.. (2016). Pricing Carbon Consumption: A Review of an Emerging Trend. SSRN Electronic Journal. 1 indexed citations
12.
Szulecki, Kacper, Severin Fischer, Anne Therese Gullberg, & Oliver Sartor. (2016). Shaping the ‘Energy Union': between national positions and governance innovation in EU energy and climate policy. Climate Policy. 16(5). 548–567. 114 indexed citations
13.
Neuhoff, Karsten, et al.. (2015). Leakage protection for carbon-intensive materials post-2020. Econstor (Econstor). 5. 397–404. 1 indexed citations
14.
Spencer, Tom, et al.. (2014). La Unión Europea y la revolución americana de los no convencionales. 27–38.
15.
Neuhoff, Karsten, et al.. (2014). Energie- und Klimapolitik: Europa ist nicht allein. Econstor (Econstor). 81(6). 91–108. 1 indexed citations
16.
Neuhoff, Karsten, B. Vanderborght, Roland Ismer, et al.. (2014). Carbon control and competitiveness post 2020: the cement report. London School of Economics and Political Science Research Online (London School of Economics and Political Science). 16 indexed citations
17.
Sartor, Oliver, et al.. (2014). The EU's 2030 climate and energy framework and energy security. Cadmus - EUI Research Repository (European University Institute). 11 indexed citations
18.
Sartor, Oliver, et al.. (2014). Benchmark-based allocations in EU ETS Phase 3: an early assessment. Climate Policy. 14(4). 507–524. 24 indexed citations
19.
Baum, Caitlin E., et al.. (2010). Androgen receptor sequence and variations in several common prostate cancer cell lines. Cancer Biology & Therapy. 9(5). 383–388. 6 indexed citations
20.
Small, Eric J., Robert A. Figlin, Daniel P. Petrylak, et al.. (2000). A Phase II Pilot Study of KW-2189 in Patients with Advanced Renal Cell Carcinoma. Investigational New Drugs. 18(2). 193–198. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026